14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 17, 2026
NMR vs EVR: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 17, 2026, Nomura Holdings, Inc (NMR) is the stronger overall head-to-head candidate over Evercore Inc. (EVR) in the Tradestie Institutional Equity Comparison Engine, winning 9–1 core matrix metrics and 3–3 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). NMR carries a Unified Composite Score of 44.5/100 (HOLD) at $9.34 (12.7x Forward P/E, 25.1% operating margin), whereas EVR carries 40.2/100 (SELL) at $290.13 (13.7x Forward P/E, 22.1% operating margin).
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on NMR vs EVR. Trailing 12-month operating profitability (NMR 25.1% vs EVR 22.1%) and valuation multiples (NMR 12.7x vs EVR 13.7x Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Capital Markets value chain with $28.3B market capitalization and 25.1% operating margin.
OpEx & R&D Reinvestment52.3% of Rev ($7.77B)
90D Engineering Disclosures0 Published
EVR Moat ProfileHigh-Margin Pricing Power Moat
Capital Markets Operator
Competes within the Capital Markets value chain with $11.3B market capitalization and 22.1% operating margin.
OpEx & R&D Reinvestment71.6% of Rev ($3.46B)
90D Engineering Disclosures0 Published
Investor FAQ NMR vs EVR Key Questions & Quantitative Answers
As of Nov 17, 2026, Nomura Holdings, Inc (NMR) is the stronger overall head-to-head candidate over Evercore Inc. (EVR) in the Tradestie Institutional Equity Comparison Engine, winning 9–1 core matrix metrics and 3–3 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). NMR carries a Unified Composite Score of 44.5/100 (HOLD) at $9.34 (12.7x Forward P/E, 25.1% operating margin), whereas EVR carries 40.2/100 (SELL) at $290.13 (13.7x Forward P/E, 22.1% operating margin). Technically, NMR sits in a Neutral phase (RSI 45.5, UNCLASSIFIED options structure) and EVR sits in a Neutral phase (RSI 54.5, CONSOLIDATION options structure).
NMR leads the Growth & Scale pillar: NMR posts +17.9% YoY revenue growth and +13.6% YoY earnings growth on $14.9B TTM revenue (77.4% gross margin, 25.1% operating margin), compared with EVR at +12.4% YoY revenue growth and +15.2% YoY earnings growth on $4.84B TTM revenue (93.7% gross margin, 22.1% operating margin). On trailing 12-month operating scale, NMR generates $14.9B in USD-normalized revenue versus $4.84B for EVR. In operating R&D and SG&A reinvestment, NMR deploys 52.3% of Rev ($7.77B) (0 90-day corporate R&D disclosures) versus 71.6% of Rev ($3.46B) (0 disclosures) for EVR.
NMR screens cheaper on headline valuation multiples. NMR trades at 12.7x Forward P/E, 11.2x Trailing P/E, 0.81x PEG, and 1.9x EV/Revenue (unreported cash flow margin), whereas EVR trades at 13.7x Forward P/E, 16.2x Trailing P/E, 1.19x PEG, and 2.3x EV/Revenue (35.7% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against NMR (11.5% ROE) versus EVR (38.0% ROE) capital efficiency.
In options market volatility and institutional positioning, NMR carries 30.7% implied volatility (<1st %ile, Compressed (<25th %ile)), thin ADR options open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.03β · 29% Vol realized risk). By comparison, EVR carries 62.6% implied volatility (14th %ile, Compressed (<25th %ile)), a 16.83x (Put-Skewed) Put/Call open-interest ratio, NEUTRAL on-balance volume, and sits in a CONSOLIDATION options structure phase (1.56β · 57% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 17, 2026. For educational research only; not investment advice.